9,315 Shares in U.S. Physical Therapy, Inc. $USPH Acquired by Integrity Alliance LLC.

Integrity Alliance LLC. purchased a new position in U.S. Physical Therapy, Inc. (NYSE:USPH) in the 3rd quarter, HoldingsChannel reports. The firm purchased 9,315 shares of the company’s stock, valued at approximately $799,000.

Other large investors have also added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of U.S. Physical Therapy in the second quarter valued at approximately $30,000. Integrated Wealth Concepts LLC acquired a new position in shares of U.S. Physical Therapy in the second quarter worth about $33,000. Sterling Capital Management LLC raised its stake in U.S. Physical Therapy by 221.0% during the 3rd quarter. Sterling Capital Management LLC now owns 443 shares of the company’s stock valued at $38,000 after acquiring an additional 305 shares in the last quarter. Parallel Advisors LLC raised its holdings in U.S. Physical Therapy by 75.2% during the 1st quarter. Parallel Advisors LLC now owns 785 shares of the company’s stock worth $59,000 after buying an additional 337 shares during the period. Finally, HighTower Advisors LLC acquired a new position in U.S. Physical Therapy during the second quarter valued at approximately $202,000.

U.S. Physical Therapy News Summary

Here are the key news stories impacting U.S. Physical Therapy this week:

• Positive Sentiment: USPH reported third-quarter earnings of $0.80 per share, ahead of the $0.76 consensus estimate, while revenue of $222.56 million topped expectations of $214.48 million and increased 12.9% year over year. U.S. Physical Therapy Tops Q3 Earnings and Revenue Estimates
• Positive Sentiment: Management reaffirmed full-year EBITDA guidance of $102 million to $106 million. Hospital revenue grew to more than 13%, offering another sign of business momentum. USPH Reaffirms EBITDA Guidance as Hospital Revenue Rises
• Positive Sentiment: Barrington Research raised its price target from $98 to $110 and maintained an “outperform” rating, signaling increased analyst confidence. Barrington Research Recommendations
• Positive Sentiment: The board declared a quarterly dividend of $0.46 per share, payable December 11 to shareholders of record November 16. The annualized dividend is $1.84, equivalent to a 2.1% yield at the cited share price. US Physical Therapy Declares New Quarterly Dividend

U.S. Physical Therapy Trading Up 2.9%

Shares of U.S. Physical Therapy stock opened at $100.02 on Friday. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.48. The business has a fifty day simple moving average of $84.20 and a 200-day simple moving average of $77.04. U.S. Physical Therapy, Inc. has a fifty-two week low of $58.19 and a fifty-two week high of $101.18. The firm has a market cap of $1.49 billion, a price-to-earnings ratio of -74.09, a price-to-earnings-growth ratio of 2.16 and a beta of 1.16.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.76 by $0.04. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%. The firm had revenue of $222.56 million for the quarter, compared to analyst estimates of $214.48 million. During the same period in the prior year, the firm posted $0.66 EPS. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. On average, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.89 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 11th. Shareholders of record on Monday, November 16th will be given a dividend of $0.46 per share. The ex-dividend date of this dividend is Monday, November 16th. This represents a $1.84 dividend on an annualized basis and a yield of 1.8%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 1,082.35%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. Barrington Research lifted their price target on U.S. Physical Therapy from $98.00 to $110.00 and gave the stock an “outperform” rating in a research note on Friday. Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. Finally, JPMorgan Chase & Co. increased their target price on U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $101.25.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.